Aclaris Therapeutics (ACRS) Current Assets: 2017-2025
Historic Current Assets for Aclaris Therapeutics (ACRS) over the last 9 years, with Sep 2025 value amounting to $100.6 million.
- Aclaris Therapeutics' Current Assets fell 23.98% to $100.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.6 million, marking a year-over-year decrease of 23.98%. This contributed to the annual value of $126.0 million for FY2024, which is 2.25% down from last year.
- Latest data reveals that Aclaris Therapeutics reported Current Assets of $100.6 million as of Q3 2025, which was down 3.46% from $104.2 million recorded in Q2 2025.
- Aclaris Therapeutics' 5-year Current Assets high stood at $259.4 million for Q2 2022, and its period low was $100.6 million during Q3 2025.
- Over the past 3 years, Aclaris Therapeutics' median Current Assets value was $126.0 million (recorded in 2024), while the average stood at $126.7 million.
- Per our database at Business Quant, Aclaris Therapeutics' Current Assets spiked by 256.62% in 2021 and then slumped by 52.03% in 2023.
- Quarterly analysis of 5 years shows Aclaris Therapeutics' Current Assets stood at $205.0 million in 2021, then rose by 12.93% to $231.6 million in 2022, then slumped by 44.35% to $128.9 million in 2023, then dropped by 2.25% to $126.0 million in 2024, then dropped by 23.98% to $100.6 million in 2025.
- Its Current Assets stands at $100.6 million for Q3 2025, versus $104.2 million for Q2 2025 and $108.8 million for Q1 2025.